Solventum (SOLV) Cash from Financing Activities (2023 - 2026)
Solventum (SOLV) reported Cash from Financing Activities of -$50.0 million for Q1 2026, up 64.03% on a YoY basis from -$30.5 million in Q1 2025, and up 56.52% quarter-over-quarter from -$115.0 million in Q4 2025.
Solventum (SOLV) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Solventum has reported Cash from Financing Activities for 4 years, with the latest figure at -$50.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 64.03% year-over-year to -$50.0 million; the trailing twelve-month figure through Mar 2026 stood at -$3.0 billion (down 252.91% YoY), and the FY2025 full-year result was -$3.1 billion, down 1173.75% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$50.0 million, up from -$115.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $462.0 million in Q1 2024, with the low at -$2.7 billion in Q3 2025.
- Historically, Cash from Financing Activities has averaged -$376.8 million across 4 years, with a median of -$202.0 million in 2024.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 200.0% — and 2025, when it slumped 1233.17%.
- Solventum's Cash from Financing Activities stood at -$306.0 million in 2023, then surged by 66.01% to -$104.0 million in 2024, then fell by 10.58% to -$115.0 million in 2025, then surged by 56.52% to -$50.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$50.0 million (Q1 2026), -$115.0 million (Q4 2025), and -$2.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -230.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.00 Mn |
| Mar 31, 2026 | -50.00 Mn |
| Dec 31, 2025 | -115.00 Mn |
| Dec 31, 2025 | -115.00 Mn |
| Sep 30, 2025 | -2.69 Bn |
| Sep 30, 2025 | -2.69 Bn |
| Jun 30, 2025 | -110.00 Mn |
| Jun 30, 2025 | -110.00 Mn |
| Mar 31, 2025 | -139.00 Mn |
| Mar 31, 2025 | -139.00 Mn |
| Dec 31, 2024 | -104.00 Mn |
| Dec 31, 2024 | -104.00 Mn |
| Sep 30, 2024 | -202.00 Mn |
| Sep 30, 2024 | -202.00 Mn |
| Jun 30, 2024 | -396.00 Mn |
| Jun 30, 2024 | -396.00 Mn |
| Mar 31, 2024 | 462.00 Mn |
| Mar 31, 2024 | 462.00 Mn |
| Dec 31, 2023 | -306.00 Mn |
| Dec 31, 2023 | -306.00 Mn |